Stephen W Webster Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen W Webster.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen W Webster. Stephen W Webster is SVP Finance & CFO in ADOLOR CORP ($ADLR) and SVP, Finance & CFO in ADOLOR CORP ($ADLR) and Chief Financial Officer in Spark Therapeutics, Inc. ($ONCE) and Director in Viking Therapeutics, Inc. ($VKTX) and Director in Nabriva Therapeutics plc ($NBRV) and Director in NextCure, Inc. ($NXTC) and Director in Nabriva Therapeutics Plc ($NBRV) and Director in TCR2 THERAPEUTICS INC. ($TCRR).
Latest Insider Trading Transactions of Stephen W Webster
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, NBRV, NBRV, NXTC, ONCE, TCRR, VKTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Webster Stephen W | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Jul 31 2020 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.79 | 35,000 | 27,650 | 35,000 | |
| Jul 31 2020 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Grant | A | 0.00 | 17,500 | 0 | 25,500 | 8 K to 25.5 K (+218.75 %) |
| Jun 15 2020 | NXTC | NextCure, Inc. | Webster Stephen W | Director | Option Exercise | A | 24.13 | 14,250 | 343,853 | 14,250 | |
| May 04 2020 | TCRR | TCR2 THERAPEUTICS ... | Webster Stephen W | Director | Option Exercise | A | 9.54 | 10,482 | 99,998 | 10,482 | |
| Jan 03 2020 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Option Exercise | A | 7.95 | 22,000 | 174,900 | 22,000 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 0.00 | 19,500 | 0 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 0.00 | 19,500 | 0 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 3.45 | 106,015 | 365,752 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 3.45 | 106,015 | 365,752 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 68.45 | 60,000 | 4,107,000 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 68.45 | 60,000 | 4,107,000 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 40.44 | 55,000 | 2,224,200 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 40.44 | 55,000 | 2,224,200 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 56.17 | 25,000 | 1,404,250 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 56.17 | 25,000 | 1,404,250 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 50.55 | 28,000 | 1,415,400 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 50.55 | 28,000 | 1,415,400 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Sell | U | 114.50 | 6,102 | 698,679 | 0 | 6.1 K to 0 (-100.00 %) |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Sell | U | 114.50 | 6,102 | 698,679 | 0 | 6.1 K to 0 (-100.00 %) |
| Aug 01 2019 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Jun 17 2019 | NXTC | NextCure, Inc. | Webster Stephen W | Director | Option Exercise | A | 15.57 | 22,000 | 342,540 | 22,000 | |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,000 | 0 | 6,000 | |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,750 | 0 | 3,500 | |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Payment of Exercise | F | 45.08 | 629 | 28,355 | 6,102 | 6.7 K to 6.1 K (-9.34 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 0.00 | 2,000 | 0 | 6,731 | 4.7 K to 6.7 K (+42.27 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Payment of Exercise | F | 45.08 | 634 | 28,581 | 4,731 | 5.4 K to 4.7 K (-11.82 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 0.00 | 1,750 | 0 | 5,365 | 3.6 K to 5.4 K (+48.41 %) |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 42.73 | 35,000 | 1,495,550 | 35,000 | |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 42.73 | 35,000 | 1,495,550 | 35,000 | |
| Jan 03 2019 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Option Exercise | A | 8.32 | 22,000 | 183,040 | 22,000 | |
| May 31 2018 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Buy | P | 5.21 | 8,000 | 41,712 | 8,000 | 0 to 8 K |
| May 23 2018 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Buy | P | 4.59 | 8,000 | 36,720 | 8,000 | 0 to 8 K |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,750 | 0 | 5,250 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 50.55 | 28,000 | 1,415,400 | 28,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Payment of Exercise | F | 50.55 | 635 | 32,099 | 3,615 | 4.3 K to 3.6 K (-14.94 %) |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 0.00 | 1,750 | 0 | 4,250 | 2.5 K to 4.3 K (+70.00 %) |
| Nov 20 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 10,000 | 34,500 | 106,015 | |
| Nov 20 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 70.14 | 10,000 | 701,400 | 2,500 | 12.5 K to 2.5 K (-80.00 %) |
| Nov 20 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 10,000 | 34,500 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Aug 15 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 10,000 | 34,500 | 116,015 | |
| Aug 15 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 79.38 | 10,000 | 793,800 | 2,500 | 12.5 K to 2.5 K (-80.00 %) |
| Aug 15 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 10,000 | 34,500 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Aug 02 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 2,337 | 8,063 | 126,015 | |
| Aug 02 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 71.12 | 2,337 | 166,207 | 2,500 | 4.8 K to 2.5 K (-48.32 %) |
| Aug 02 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 2,337 | 8,063 | 4,837 | 2.5 K to 4.8 K (+93.48 %) |
| Jun 27 2017 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | J | 0.00 | 10,100 | 0 | 10,100 | |
| Jun 27 2017 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | J | 0.00 | 20,200 | 0 | 20,200 | |
| Jun 21 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 7,663 | 26,437 | 128,352 | |
| Jun 21 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 60.00 | 7,663 | 459,780 | 2,500 | 10.2 K to 2.5 K (-75.40 %) |
| Jun 21 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 7,663 | 26,437 | 10,163 | 2.5 K to 10.2 K (+306.52 %) |
| Apr 26 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 8,102 | 27,952 | 136,015 | |
| Apr 26 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 1,898 | 6,548 | 144,117 | |
| Apr 26 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 55.22 | 8,102 | 447,392 | 2,500 | 10.6 K to 2.5 K (-76.42 %) |
| Apr 26 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 8,102 | 27,952 | 10,602 | 2.5 K to 10.6 K (+324.08 %) |
| Apr 26 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 55.00 | 1,898 | 104,390 | 2,500 | 4.4 K to 2.5 K (-43.16 %) |
| Apr 26 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 1,898 | 6,548 | 4,398 | 2.5 K to 4.4 K (+75.92 %) |
| Jan 20 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
| Jan 20 2017 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 56.17 | 25,000 | 1,404,250 | 25,000 | |
| Jan 05 2017 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Option Exercise | A | 1.19 | 16,000 | 19,040 | 16,000 | |
| May 24 2016 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 20,000 | 69,000 | 146,015 | |
| May 24 2016 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 50.38 | 9,000 | 453,420 | 2,500 | 11.5 K to 2.5 K (-78.26 %) |
| May 24 2016 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 50.40 | 11,000 | 554,400 | 11,500 | 22.5 K to 11.5 K (-48.89 %) |
| May 24 2016 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 20,000 | 69,000 | 22,500 | 2.5 K to 22.5 K (+800.00 %) |
| Jan 07 2016 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 40.44 | 55,000 | 2,224,200 | 55,000 | |
| Jan 06 2016 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Option Exercise | A | 3.33 | 16,000 | 53,280 | 16,000 | |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | M | 3.45 | 20,000 | 69,000 | 166,015 | |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Sell | S | 48.86 | 20,000 | 977,200 | 2,500 | 22.5 K to 2.5 K (-88.89 %) |
| Oct 09 2015 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Buy | M | 3.45 | 20,000 | 69,000 | 22,500 | 2.5 K to 22.5 K (+800.00 %) |
| Apr 30 2015 | VKTX | Viking Therapeutic ... | Webster Stephen W | Director | Option Exercise | A | 8.00 | 20,786 | 166,288 | 20,786 | |
| Mar 18 2015 | ONCE | Spark Therapeutics ... | Webster Stephen W | Chief Financial Off ... | Option Exercise | A | 68.45 | 60,000 | 4,107,000 | 60,000 | |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Option Exercise | M | 1.34 | 17,503 | 23,454 | 0 | |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Option Exercise | M | 1.34 | 52,497 | 70,346 | 0 | |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Option Exercise | M | 1.77 | 10,787 | 19,093 | 0 | |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Option Exercise | M | 1.77 | 49,213 | 87,107 | 0 | |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Sell | J | 4.25 | 281,250 | 1,195,313 | 0 | 281.3 K to 0 (-100.00 %) |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Buy | M | 1.34 | 17,503 | 23,454 | 281,250 | 263.7 K to 281.3 K (+6.64 %) |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Buy | M | 1.34 | 52,497 | 70,346 | 263,747 | 211.3 K to 263.7 K (+24.85 %) |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Buy | M | 1.77 | 10,787 | 19,093 | 211,250 | 200.5 K to 211.3 K (+5.38 %) |
| Dec 14 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Buy | M | 1.77 | 49,213 | 87,107 | 200,463 | 151.3 K to 200.5 K (+32.54 %) |
| Aug 19 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Grant | A | 0.00 | 13,750 | 0 | 151,250 | 137.5 K to 151.3 K (+10.00 %) |
| Jun 27 2011 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Buy | P | 1.88 | 10,000 | 18,800 | 137,500 | 127.5 K to 137.5 K (+7.84 %) |
| Sep 13 2010 | ADLR | ADOLOR CORP | Webster Stephen W | SVP, Finance & CFO | Grant | A | 0.00 | 82,500 | 0 | 127,500 | 45 K to 127.5 K (+183.33 %) |
| Dec 17 2009 | ADLR | ADOLOR CORP | Webster Stephen W | SVP Finance & CFO | Option Exercise | A | 1.34 | 70,000 | 93,800 | 70,000 | |
| Dec 17 2009 | ADLR | ADOLOR CORP | Webster Stephen W | SVP Finance & CFO | Grant | A | 0.00 | 45,000 | 0 | 45,000 | 0 to 45 K |
| Jan 08 2009 | ADLR | ADOLOR CORP | Webster Stephen W | SVP Finance & CFO | Option Exercise | A | 1.77 | 60,000 | 106,200 | 60,000 |
Page: 1